The Law Offices of Frank R. Cruz announces an investigation of ICU Medical, Inc. (“ICU Medical” or the “Company”) (NASDAQ: ICUI) on behalf of investors concerning the Company’s possible violations of federal securities laws.

What Is The Investigation About?
On April 22, 2025, the FDA published a warning letter issued to ICU Medical stating that the Company had “made multiple changes to the Medfusion Model 4000 Syringe Infusion Pump and CADD Solis VIP Ambulatory Infusion Pump that could significantly affect the safety or effectiveness of these devices.” The warning letter stated the subject pumps were “adulterated” and “misbranded” and noted the Company’s modifications “can significantly impact the functionality of the device with respect to the infusion pumps delivery profile, alarm functionality, etc., and affect the device’s risk profile.”

On this news, ICU Medical’s stock price fell as much as 7% during intraday trading on April 22, 2025, thereby injuring investors.